Truvian Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
119
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$74M
- Investors
-
19
Truvian General Information
Description
Developer of an automated blood testing and diagnostic technology designed to deliver a convenient and affordable alternative to off-site labs. The company's technology combines clinical chemistries, immunoassays, and hematology assays all within one instrument, in a single run and provides lab-accurate results in less time for a suite of health tests, enabling healthcare professionals to get access to comprehensive, easy-to-understand lab test reports and insights while also making routine health testing suitable and reasonable.
Contact Information
Website
www.truvianhealth.comCorporate Office
- 10300 Campus Point Drive
- Suite 190
- San Diego, CA 92121
- United States
Corporate Office
- 10300 Campus Point Drive
- Suite 190
- San Diego, CA 92121
- United States
Truvian Timeline
Truvian Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series D) | 17-Jul-2024 | $74M | Completed | Generating Revenue | ||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series C) | 01-Jul-2023 | Completed | Generating Revenue | |||
| 6. Debt - General | 14-Sep-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 19-Feb-2021 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 28-Apr-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 30-May-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Jan-2019 | $17.3M | $19.3M | Completed | Generating Revenue | |
| 1. Early Stage VC | 12-Oct-2015 | $2M | $2M | Completed | Startup |
Truvian Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 857,512,088 | $0.000100 | $0.13 | $0.02 | $0.02 | 1x | $0.02 | 17.98% |
| Seed | 333,333,300 | $0.000100 | $0.05 | $0.01 | $0.01 | 1x | $0.01 | 6.99% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Truvian Comparisons
Industry
Financing
Details
Truvian Competitors (5)
One of Truvian’s 5 competitors is 1Drop, a Formerly VC-backed company based in Neuchatel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 1Drop | Formerly VC-backed | Neuchatel, Switzerland | ||||
| Sight Diagnostics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Genalyte | Venture Capital-Backed | San Diego, CA | ||||
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| LetsGetChecked | Venture Capital-Backed | Dublin, Ireland |
Truvian Patents
Truvian Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4520432-A1 | Optical multianalyte detection | Pending | 08-Sep-2023 | ||
| US-12287321-B2 | Optical multianalyte detection | Active | 08-Sep-2023 | ||
| US-20250085271-A1 | Optical multianalyte detection | Active | 08-Sep-2023 | ||
| US-20250369952-A1 | Optical multianalyte detection | Pending | 08-Sep-2023 | ||
| WO-2025054058-A1 | Optical multianalyte detection | Inactive | 08-Sep-2023 | G01N33/492 |
Truvian Signals
Truvian Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HSBC Ventures | Corporate Venture Capital | Minority | ||
| Fanjul Capital | PE/Buyout | Minority | ||
| Medical Excellence Capital | Venture Capital | Minority | ||
| Spring Creek Partners | Family Office | Minority | ||
| General Catalyst | Venture Capital | Minority |
Truvian FAQs
-
When was Truvian founded?
Truvian was founded in 2015.
-
Where is Truvian headquartered?
Truvian is headquartered in San Diego, CA.
-
What is the size of Truvian?
Truvian has 119 total employees.
-
What industry is Truvian in?
Truvian’s primary industry is Diagnostic Equipment.
-
Is Truvian a private or public company?
Truvian is a Private company.
-
What is the current valuation of Truvian?
The current valuation of Truvian is .
-
What is Truvian’s current revenue?
The current revenue for Truvian is .
-
How much funding has Truvian raised over time?
Truvian has raised $294M.
-
Who are Truvian’s investors?
HSBC Ventures, Fanjul Capital, Medical Excellence Capital, Spring Creek Partners, and General Catalyst are 5 of 19 investors who have invested in Truvian.
-
Who are Truvian’s competitors?
1Drop, Sight Diagnostics, Genalyte, Autogenomics, and LetsGetChecked are competitors of Truvian.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process